{"id":11752,"date":"2018-10-16T08:42:16","date_gmt":"2018-10-16T12:42:16","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11752"},"modified":"2018-10-16T08:42:16","modified_gmt":"2018-10-16T12:42:16","slug":"tv-ads-must-trumpet-drug-prices-trump-administration-says-pharma-tries-a-plan-b","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11752","title":{"rendered":"TV Ads Must Trumpet Drug Prices, Trump Administration Says. Pharma Tries A Plan B."},"content":{"rendered":"

(By Shefali Luthra and Sarah Jane Tribble for Kaiser Health News)<\/p>\n

The Trump administration proposed Monday that drugmakers reveal the list prices of their medicines in television ads, effectively setting the stage for months or possibly years of battle with the powerful industry.<\/p>\n

The proposal, released late in the day, would require pharmaceutical companies to include in its television advertising the price of any drug that cost more than $35 a month. The price should be listed at the end of the advertisement in \u201ca legible manner,\u201d the rule states. It goes on to explain that the price should be presented against a contrasting background in a way that is easy to read. Continue to read article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Shefali Luthra and Sarah Jane Tribble for Kaiser Health News) The Trump administration proposed Monday that drugmakers reveal the<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,20,10,15],"tags":[],"class_list":["post-11752","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-health-care-redesign","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11752"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11752\/revisions"}],"predecessor-version":[{"id":11753,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11752\/revisions\/11753"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}